Open in interactive viewer → charts, metric popovers & call review

One Stop Systems Raises Guidance 40%, and the Market Hands Back 63%

The edge-compute story is converting into production orders — just as the AI-datacenter complex that carried the stock to $19.95 in June has cracked; and the $100 million programs the equity was really pricing remain strictly off-guidance.
OSS · Earnings Call · 2026-10-28

A raise nobody wanted

On the numbers, One Stop Systems just posted the cleanest quarter of its post-Bressner life. Revenue from continuing operations came in at $12.6 million, up roughly 36% year over year, taking nine-month revenue to $30 million, up about 48%. Management lifted full-year growth guidance to approximately 40% — from 25%–30% three months ago, and 20%–25% when the year began — and reiterated gross margin of 40%–42% with adjusted EBITDA of $0.5 million to $1 million. The stock's answer was brutal. OSS is down 63.3% over the last 90 trading days and sits 68.7% below its June 2 peak of $19.95, a drawdown that has taken a $156 million market cap down to roughly $6.25 a share. That is not a company-specific verdict as much as a sector one. The global tape shows AI data center down 5.4% with six advancers against fifty decliners across both the 90- and 30-day windows, High bandwidth flash off 7.5%, and PCIe Gen 6 down 7.5% on the back of CRDO, SIMO, ALAB and MRVL. OSS is a levered beta on a trade that stopped paying. Which makes the honest read of this call a bit uncomfortable: the fundamentals inflected right at the moment the multiple deflated. Price to revenue peaked near 19.5x on the last reported quarter — that figure is now stale by one enormous drawdown.

What is genuinely working: bookings becoming boxes

The conversion machinery is real, and it is the strongest part of the quarter. Year-to-date bookings of $43.6 million against $30 million of revenue gives a book-to-bill of 1.46; the company says bookings have exceeded revenue in every quarter of 2026. Average order size has nearly tripled since 2023, and the count of multiyear program positions has gone from one to fourteen. Knowles framed the change plainly: “Our growth is increasingly supported by a broader set of applications and customers rather than being driven solely by the timing of one large order.” — Michael Knowles, Chief Executive Officer · 2026-10-28 The proof points are specific. A liquid-cooled medical imaging program for breast cancer screening is now meaningful production revenue. Commercial aerospace in-flight entertainment deliveries rose. A new autonomous energy node customer began taking shipments. The commercial robotics program — promised on the May call to transition to production this year — did: “we'll be transitioning that program to production here in 2026” — Michael Knowles, CEO · 2026-05-06, now a $2.2 million initial order with a $10–15 million, five-year path. On defense, an $8.4 million initial award on an intelligence-related compute platform sits inside what management believes is a ~$44 million opportunity over four years. That is a company that kept a promise. So why the collapse? Partly because the newest product qualification leans on yesterday's standard. The headline enterprise win is a Gen 5 4UP-MAX expansion system qualified with a Tier 1 global enterprise platform provider — a genuinely useful door-opener into data centers, which has been OSS's top keyword for the better part of two years. But in the prior quarter's keyword set, PCIe Gen 6 ranked in the company's own top ten; this quarter it is gone, replaced by Gen 5. OSS is selling an expansion chassis into a conversation that has already moved a generation ahead.

The $100 million asterisk

The freshest language on the call — and the newest keyword in the company's entire tracked history, ranking sixth this quarter — is transformative opportunity. When pressed on size and timing, Knowles gave it a number:

these would be programs that would tend to look more like $100 million or greater over a 3-, 4-year period. These are kind of like your larger normal programs of record in defense or a large deployment in commercial applications.

Michael Knowles, Chief Executive Officer · 2026-10-28
Then came the two sentences that matter more than the size. Asked whether any of it was in guidance: “They are not included in the 2026 guidance. They're more longer term.” — Michael Knowles, Chief Executive Officer · 2026-10-28 And from the CFO: “All of our guidance for 2026 is in backlog.” — Daniel Gabel, Chief Financial Officer · 2026-10-28 At $19.95, the equity was discounting the $100 million programs. At $6.25, it is discounting the backlog. That is the whole repricing in two sentences. The caution is earned by history. The Army 360 situational awareness system has been the marquee "transformative" candidate for at least three quarters. In August, Knowles described its status as “more or less an undefined testing phase” — Michael Knowles, CEO · 2026-08-05. On this call it is still testing and evaluation, now extended into enhanced vision for brownout driving and a sensor-distribution role for counter-UAS: “That continues to be -- remain in test and evaluation.” — Michael Knowles, Chief Executive Officer · 2026-10-28 Meanwhile Golden Dome, a top-five keyword for OSS just one quarter ago and a topic the CEO engaged at length in August, vanished from the keyword set entirely — no analyst asked, and management did not volunteer it. What a company stops saying is often the loudest signal.

Cash, cleanup, and the quiet tell

The balance sheet is not distressed: $18.9 million of cash and short-term investments with no debt. But the direction of travel is. Nine-month operating cash use was $12.4 million, including a $6.25 million settlement payment and a $7.8 million inventory build to pre-buy memory ahead of extended lead times. Receivables closed at $12.7 million against $2.1 million of payables, and “We did have about $5.6 million of milestone collections that we had hoped would close in Q3. We now expect those in October.” — Daniel Gabel, Chief Financial Officer · 2026-10-28 Two new cost lines also entered the company's top-five keywords for the first time — bad debt ($544,000 tied to a customer bankruptcy, fully reserved) and legal settlement ($394,000 of expense on a settlement executed in the quarter). Strip them out and adjusted EBITDA would have been roughly $1.2 million, near 10% of revenue; reported, it was $0.3 million. And then the tell. Alongside a raise to 40% growth, OSS established an at-the-market equity program — the second capital-markets action in about a year, following a $12.5 million registered direct in late 2025. Guidance of $0.5–1 million of full-year EBITDA on ~$45 million of revenue means the operating model still funds itself from the equity window, not the P&L. R&D was $853,100 against $9 million of quarterly revenue. Gross margin of 39.1% in the June quarter flatters the story only if you ignore that Q4 is guided lower.

The bottom line

Thesis intact, multiple destroyed. OSS is converting a pipeline into production in medical imaging, aerospace, robotics and defense intelligence, and doing it at a book-to-bill of 1.46 — that is a different company than the one that wandered through 2023 and 2024. But the price it commanded in June was built on transformative opportunity language that management repeatedly declines to put in a number, while the pipeline realists inside the Army are still, three quarters running, evaluating. Until one of those $100 million programs leaves test and evaluation, the stock is a 3.5x forward-sales hardware story with a thin EBITDA line and an open ATM — which is roughly what it now trades for.